← Back to headlines
Ultragenyx Pharmaceutical Shares Plunge 45% Following Major Corporate Announcement
Shares of biotech firm Ultragenyx plummeted by nearly half in intraday trading following a significant corporate disclosure that triggered severe investor sell-offs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
